Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study.

Spargias K, Adreanides E, Giamouzis G, Karagiannis S, Gouziouta A, Manginas A, Voudris V, Pavlides G, Cokkinos DV.

Eur J Clin Pharmacol. 2006 Aug;62(8):589-95. Epub 2006 Jul 11.

PMID:
16832680
2.

Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Spargias K, Adreanides E, Demerouti E, Gkouziouta A, Manginas A, Pavlides G, Voudris V, Cokkinos DV.

Circulation. 2009 Nov 3;120(18):1793-9. doi: 10.1161/CIRCULATIONAHA.109.863159. Epub 2009 Oct 19.

3.

A Review of the Use of Iloprost, A Synthetic Prostacyclin, in the Prevention of Radiocontrast Nephropathy in Patients Undergoing Coronary Angiography and Intervention.

Kassis HM, Minsinger KD, McCullough PA, Block CA, Sidhu MS, Brown JR.

Clin Cardiol. 2015 Aug;38(8):492-8. doi: 10.1002/clc.22407. Epub 2015 May 12. Review.

4.

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.

Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW; CONTRAST Investigators.

JAMA. 2003 Nov 5;290(17):2284-91.

PMID:
14600187
5.

Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV.

Circulation. 2004 Nov 2;110(18):2837-42. Epub 2004 Oct 18. Erratum in: Circulation. 2005 Jan 25;111(3):379. Iacovis, Panagiotis [corrected to Iokovis,Panagiotis].

6.

Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.

Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, Schweigart U, Lutilsky L, Valina C, Seyfarth M, Schömig A, Classen M.

Am J Cardiol. 2003 May 15;91(10):1157-62.

PMID:
12745095
7.

Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.

Bilasy ME, Oraby MA, Ismail HM, Maklady FA.

J Interv Cardiol. 2012 Aug;25(4):404-10. doi: 10.1111/j.1540-8183.2012.00730.x. Epub 2012 May 22.

PMID:
22612071
8.
9.

Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.

Huber W, Ilgmann K, Page M, Hennig M, Schweigart U, Jeschke B, Lutilsky L, Weiss W, Salmhofer H, Classen M.

Radiology. 2002 Jun;223(3):772-9.

PMID:
12034949
10.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
11.
12.

Radiocontrast nephropathy: is it dose related or not?

Mekan SF, Rabbani MA, Azhar-uddin M, Ali SS.

J Pak Med Assoc. 2004 Jul;54(7):372-4.

13.

Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.

Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M.

Am J Cardiol. 2007 Sep 1;100(5):781-6. Epub 2007 Jun 13.

PMID:
17719320
14.
15.

Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.

Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, Youn TJ, Chung WY, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.

Am Heart J. 2008 Mar;155(3):499.e1-8. doi: 10.1016/j.ahj.2007.11.042. Epub 2008 Jan 30.

PMID:
18294484
16.

Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.

Uddin MA, Rabbani MA, Jafary FH, Bhatti MA, Islam M.

J Coll Physicians Surg Pak. 2005 Dec;15(12):791-4.

PMID:
16398973
17.

Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: a multicenter prospective randomized study.

Koc F, Ozdemir K, Altunkas F, Celik A, Dogdu O, Karayakali M, Gul EE, Erkorkmaz U, Kadi H, Akpek M, Kaya MG.

J Investig Med. 2013 Jun;61(5):872-7. doi: 10.2310/JIM.0b013e31828e9cab.

PMID:
23552179
19.

Effectiveness of acetylcysteine in prevention of contrast nephropathy.

Azmus AD, Gottschall C, Manica A, Manica J, Duro K, Frey M, Bulcão L, Lima C.

J Invasive Cardiol. 2005 Feb;17(2):80-4.

PMID:
15687530
20.

Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients.

Hansen JM, Christensen NJ, Fogh-Andersen N, Strandgaard S.

Nephrol Dial Transplant. 1996 Feb;11(2):340-6.

PMID:
8671790

Supplemental Content

Support Center